MACUSTAR Intermediate AMD: development of novel clinical endpoints for clinical trials in patients with a regulatory and patient access intention Ongoing | IMI2 | Ageing-associated diseasesEye diseasesTools for predicting/monitoring efficacyPatient involvement in R&DImaging